IVACAFTOR (Kalydeco®)

Clinical Indication

Cystic fibrosis


As per NHSE policy statement

Date of classification

November 2019


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.